| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/08/2013 | CN103088060A Vaccine composition |
| 05/08/2013 | CN103088029A Double-enhancer alpha fetoprotein (AFP) recombination promoter and application thereof |
| 05/08/2013 | CN103088028A shRNA (short hairpin ribonucleic acid) of silent human breast cancer specific gene |
| 05/08/2013 | CN103088026A Artificial miRNA for resisting hepatitis B virus and artificial miRNA combinations |
| 05/08/2013 | CN103088025A Swine fever virus-resistant peptide nucleic acid |
| 05/08/2013 | CN103088020A siRNA molecule for inhibiting production of melanin, and application thereof |
| 05/08/2013 | CN103087311A Amphipathy triblock polymer and preparation method and application thereof |
| 05/08/2013 | CN103083686A Application of DKK4 gene and coding protein thereof in preparation of medicament |
| 05/08/2013 | CN103083685A Method for reversing drug resistance of breast cancer by using miR-181a |
| 05/08/2013 | CN103083684A Method for improving immune protective rate of fasciola hepatica Cat L1 (FhCat L1) DNA (Deoxyribose Nucleic Acid) vaccine |
| 05/08/2013 | CN103083668A Protein for regulating lipid metabolism and application thereof |
| 05/08/2013 | CN103083223A Galactose modified sulfhydryl chitosan quaternary ammonium salt nanoparticle, as well as preparation method and application thereof |
| 05/08/2013 | CN102233136B Recombinant plasmid vaccine for treating hepatitis B and composition thereof |
| 05/08/2013 | CN101829367B Three-dimensional nano stent of gene delivery system, preparation method and application thereof |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8436160 Isolated DNA fragment of the SPARC human promoter and its use for driving the expression of an heterologous gene in tumor cells |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8435960 Devices for improved wound management |
| 05/07/2013 | US8435801 Methods and compositions for the production of monoclonal antibodies |
| 05/07/2013 | US8435557 Method for producing sterile polynucleotide based medicaments |
| 05/07/2013 | US8435534 Cancer immunotherapy |
| 05/07/2013 | US8435507 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders |
| 05/07/2013 | CA2581632C Biodegradable cationic polymers |
| 05/07/2013 | CA2496376C Methods of drug delivery using sulphated chitinous polymers |
| 05/07/2013 | CA2475073C Hypoallergenic polypeptides based on fish parvalbumin |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/07/2013 | CA2456184C Expression profile of prostate cancer |
| 05/07/2013 | CA2360347C Improved expression of hiv polypeptides and production of virus-like particles |
| 05/02/2013 | WO2013063482A2 Flt3 mutations associated with drug resistance in aml patients having activating mutations in flt3 |
| 05/02/2013 | WO2013063468A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | WO2013063419A2 A fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting |
| 05/02/2013 | WO2013063412A2 Methods of diagnosis and treatment of endoplasmic reticulum (er) stress-related conditions |
| 05/02/2013 | WO2013063383A2 Vectors encoding rod-derived cone viability factor |
| 05/02/2013 | WO2013063019A1 Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells |
| 05/02/2013 | WO2013062507A1 Improved hcv vaccines and methods for using the same |
| 05/02/2013 | WO2013061594A1 Topk peptides and vaccines including the same |
| 05/02/2013 | WO2013061091A2 Cystic fibrosis treatment |
| 05/02/2013 | WO2013061076A1 Construct |
| 05/02/2013 | WO2013060230A1 Sirna molecule for inhibiting growth of melanin and application thereof |
| 05/02/2013 | WO2013040295A3 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
| 05/02/2013 | WO2013036867A3 Compositions and methods for cancer and cancer stem cell detection and elimination |
| 05/02/2013 | WO2013036610A3 Compositions comprising mg53 and methods for the treatment and prevention of airway injury |
| 05/02/2013 | WO2012135868A8 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 05/02/2013 | WO2012019121A3 Multiplexed supramolecular assemblies for non-viral delivery of genetic material |
| 05/02/2013 | US20130109736 Method for enhanced uptake of viral vectors in the myocardium |
| 05/02/2013 | US20130109624 Novel neurotrophic factors |
| 05/02/2013 | US20130108704 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 05/02/2013 | US20130108667 Method, apparatus and system for electroporation |
| 05/02/2013 | US20130108613 Amyloid-beta clearance |
| 05/02/2013 | CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | CA2852633A1 Topk peptides and vaccines including the same |
| 05/02/2013 | CA2849241A1 Construct |
| 05/01/2013 | EP2586453A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 05/01/2013 | EP2585596A2 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
| 05/01/2013 | EP2585100A2 Method for predicting a therapy response in subjects with multiple sclerosis |
| 05/01/2013 | CN1662556B Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 05/01/2013 | CN103080314A Inhibitor of expression of dominantly mutated gene |
| 05/01/2013 | CN103080313A Conjugates, particles, compositions, and related methods |
| 05/01/2013 | CN103074376A Neurithin gene-carrying lentivirus and application thereof in optic nerve injury repair |
| 05/01/2013 | CN103074340A Nucleic acid and application thereof, and medicine composition |
| 05/01/2013 | CN103074339A Nucleic acid and medicine composition, and application thereof |
| 05/01/2013 | CN103073726A Block copolymer, liquid composition, nucleic acid preparation, and preparation methods and applications thereof |
| 05/01/2013 | CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof |
| 05/01/2013 | CN103073629A Protein capable of inhibiting release of virus particles, coding sequence of protein and application in inhibiting release of retrovirus from cells |
| 05/01/2013 | CN103071161A Preparation method of polycationic liposome/calcium phosphate nanoparticle drug delivery vector |
| 05/01/2013 | CN103071160A Gene vaccine for Alzheimer's disease |
| 05/01/2013 | CN102337263B siRNA (Small interfering ribonucleic acid) capable of inhibiting expression of enterovirus 71 type gene, composition and application |
| 05/01/2013 | CN102058535B Novel folate receptor targeted liposome |
| 05/01/2013 | CN101948516B Establishment and application of vaccinia virus vector-based reverse genetics system |
| 05/01/2013 | CN101760457B SiRNA inhibiting duplication of A type influenza virus and coding sequence thereof |
| 05/01/2013 | CN101671689B Recombinant expression carrier containing schistosoma japonicum gene and application thereof |
| 05/01/2013 | CN101603042B RNA interference target for treating hepatitis B virus infection |
| 04/30/2013 | US8431692 Compositions and methods for treatment of ear disorders |
| 04/30/2013 | US8431545 Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof |
| 04/30/2013 | US8431543 Chitosan based polymer conjugate and a method for producing the same |
| 04/30/2013 | US8431522 Methods of inhibiting tumor cell proliferation |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2453522C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/30/2013 | CA2417495C Methods for treating cell proliferative disorders and viral infections |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2399321C Adenovirus formulations |
| 04/25/2013 | WO2013059778A2 Antigen presenting cancer vaccine with gamma interferon |
| 04/25/2013 | WO2013059442A2 Inhibition of retinoic acid production for hiv vaccination |
| 04/25/2013 | WO2013059320A1 Treatment of cancers with mutant npm1 with mek inhibitors |
| 04/25/2013 | WO2013058306A1 Activation of functional nucleic acid by specific modification |
| 04/25/2013 | WO2013056670A1 Small interference rnas, uses thereof and method for inhibiting the expression of plk1 gene |
| 04/25/2013 | WO2013032643A3 Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| 04/25/2013 | WO2013025834A3 Compositions and methods related to antibodies to staphylococcal protein a |
| 04/25/2013 | WO2013025474A9 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 04/25/2013 | WO2013019923A3 Methods for detecting progenitor cells and uses thereof |
| 04/25/2013 | WO2013009981A9 Treating neurological disease or injury with a dynamin-related protein 1 (drp1) encoding nucleic acid |
| 04/25/2013 | WO2012174280A3 Methods and compositions for modulating myofibroblast activities |
| 04/25/2013 | WO2012162629A3 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria |
| 04/25/2013 | WO2012122025A3 Vectors conditionally expressing protein |
| 04/25/2013 | WO2011137441A3 Sparc binding aptamers and uses thereof |
| 04/25/2013 | WO2007026236A8 Electrotransfer of nucleic acid into tissue cells |
| 04/25/2013 | US20130104253 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/25/2013 | US20130103151 Dermal micro-organs, methods and apparatuses for producing and using the same |